Myron Czuczman

Author PubWeight™ 7.74^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab.	J Clin Oncol	2013	1.65
2	A Cancer and Leukemia Group B multi-center study of DA-EPOCH-rituximab in untreated diffuse large B-cell lymphoma with analysis of outcome by molecular subtype.	Haematologica	2011	1.48
3	The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large B cell lymphoma: update of the 2001 evidence-based review.	Biol Blood Marrow Transplant	2010	1.06
4	The role of surgical intervention in non-Hodgkin's lymphoma of the colon and rectum.	Am J Surg	2007	0.98
5	Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma.	Clin Lymphoma	2004	0.95
6	Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.	Mycopathologia	2005	0.94
7	Extra copies of chromosome 2 are a recurring aberration in ALK-negative lymphomas with anaplastic morphology.	Mod Pathol	2005	0.83
8	The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of diffuse large cell B-cell non-Hodgkin's lymphoma.	Biol Blood Marrow Transplant	2003	0.75